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TAR DNA binding protein of 43 kDa (TDP-43) is a
nuclear factor functioning in RNA processing. It was also
reported that TDP-43 aggregates are deposited in motor
neurons implicated in the pathogenesis of amyotrophic
lateral sclerosis (ALS) and frontotemporal lobar degenera-
tion with ubiquitin (FTLD-U). To understand the mechan-
ism underlying the inclusion body formation and possible
functional alteration of TDP-43, we studied TDP-43 and
its fragments and their effects on RNA processing in vitro
and in cell models. We have identified a hydrophobic
sequence in the C-terminus that is critical for the TDP-43
aggregation and inclusion formation. The synthetic pep-
tide with this sequence forms an a-helical structure in
solution but easily transforms into b-sheet structure. The
inclusions formed by the C-terminal 35-kDa fragment
(TDP-35) can recruit full-length TDP-43 to cytoplasmic
deposition from functionally nuclear localization. TDP-35,
rather than TDP-43 and the C-terminal 25-kDa fragment,
is prone to aggregation in vitro, and it can further serve as
a seed to facilitate aggregation of full-length TDP-43. This
suggests that fragmentation of TDP-43 leads to cellular
redistribution, inclusion body formation, and altered RNA
processing, which are implicated in the molecular patho-
genesis of ALS and FTLD.
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